car-t-cell-therapy-market-report

CAR-T Cell Therapy Market By Type of Targeted Antigens (CD19, CD20, CD22, CD30, CD33, BCMA, MSLN), By Type of Approach (Autologous and Allogeneic), By Therapeutic Areas (Acute lymphoblastic leukemia (ALL), Diffuse large B-Cell lymphoma (DLBCL), Multiple Myeloma (MM), Acute Myeloid Leukemia (AML) and Others), By Product (Axicabtagene Ciloleucel, Tisagenlecleucel, Lisocabtagene Maraleucel, Bb2121), By End Users (Hospitals, Cancer Treatment Centers) – Growth, Future prospects & Analysis 2024-2032

24 Jul 2021 Format PDF icon PPT icon XLS icon Request Sample
Choose Licence Type
$4500
$6500
$9000
Why Acute
View Other Reports